AlphaGalileo45m
Semaglutide Significantly Improves Walking Distance, Symptoms and Quality of Life for People with PAD and Diabetes
Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery ...
PharmiWeb1h
CPC Announces Semaglutide Significantly Improves Walking Distance, Symptoms and Quality of Life for People with PAD and Diabetes
Study underscores the direct vascular effects of this class of drugs, researchers say AURORA, CO / ACCESS Newswire / March 29, 2025 / A novel study of a semaglutide, a glucagon-like peptide-1 (GLP-1) ...
Scientific Research Publishing14h
Micro and Macrovascular Complications in Diabetes Mellitus ()
Keywords Diabetes Mellitus, Retinopathy, Neuropathy, Nephropathy, Cardiovascular Disease Share and Cite: Mohammed, S. , ...